Kali Care (fka Rxense) Patents

Patent portfolio assigned to Kali Care (fka Rxense) (verified via public assignee records). Estimated patent count: 1. Digital-health company for ophthalmic medication (eye-drop) adherence monitoring via smart sensors (formerly Rxense; later acquired by Santen). Patent US8998861B2 'Portable management and monitoring system for eye drop medication regiment' originated with the company and is now assigned to Santen Holdings U.S. Inc., so has_patents=true (count ~1+ confirmed). Partner Aptar Pharma. Competitor Amaros per CB Insights.